Crossref

1. State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach

- Adetutu Akinnuwesi

- Samuel Egieyeh

- Ruben Cloete

2.

3. Pharmacokinetic Correlation of Structurally Modified Chalcone Derivatives As Promising Leads to Treat Tuberculosis

- Sarvesh Sabarathinam

- Nila Ganamurali

- Sanjana Satheesh

- Dhivya Dhanasekaran

- Arun Raja

4. The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future

- Martie Van Der Walt

- Karen H. Keddy

5. Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery

- Summaya Perveen

- Rashmi Sharma

6. Structure and Function of L,D- and D,D-Transpeptidase Family Enzymes from Mycobacterium tuberculosis

- Gideon F. Tolufashe

- Victor T. Sabe

- Colins U. Ibeji

- Thandokuhle Ntombela

- Thavendran Govender

- Glenn E.M. Maguire

- Hendrik G. Kruger

- Gyanu Lamichhane

- Bahareh Honarparvar